We are live on ! Find out more
Legal & General Group

Legal & General Group Portfolio holdings

AUM $432B
1-Year Est. Return 29.4%
 

Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.

This Quarter Est. Return
+14.45%
1 Year Est. Return
+29.4%
3 Year Est. Return
+97.7%
5 Year Est. Return
+129.51%
10 Year Est. Return
+472.83%
AUM
$403B
AUM Growth
+$35.6B
Cap. Flow
-$3.24B
Cap. Flow %
-0.81%
Top 10 Hldgs %
32.43%
Holding
3,602
New
227
Increased
1,896
Reduced
1,081
Closed
186

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$342M
2
NVDA icon
NVIDIA
NVDA
+$330M
3
COF icon
Capital One
COF
+$288M
4
JNJ icon
Johnson & Johnson
JNJ
+$169M
5
AMRZ
Amrize Ltd
AMRZ
+$164M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.01B
2
MSFT icon
Microsoft
MSFT
+$999M
3
DFS
Discover Financial Services
DFS
+$296M
4
LLY icon
Eli Lilly
LLY
+$215M
5
AMZN icon
Amazon
AMZN
+$185M

Sector Composition

Rank Sector Weight
1 Technology 34.29%
2 Financials 13.54%
3 Consumer Discretionary 9.85%
4 Healthcare 9.21%
5 Communication Services 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRCA icon
3551
Verrica Pharmaceuticals
VRCA
$90.2M
-252
Closed -$1.11K
VTSI icon
3552
VirTra
VTSI
$34.6M
-1,159
Closed -$4.72K
VTYX
3553
DELISTED
Ventyx Biosciences
VTYX
-5,981
Closed -$6.91K
X
3554
DELISTED
US Steel
X
-484,760
Closed -$20.5M
XBIT icon
3555
XBiotech
XBIT
$68.1M
-1,598
Closed -$5.18K
XFOR icon
3556
X4 Pharmaceuticals
XFOR
$386M
-620
Closed -$4.4K
YSG
3557
Yatsen Holding
YSG
$307M
-7,201
Closed -$34.7K
ZNTL icon
3558
Zentalis Pharmaceuticals
ZNTL
$331M
-4,940
Closed -$7.83K
ZURA icon
3559
Zura Bio
ZURA
$524M
-4,779
Closed -$6.16K
ZYXI
3560
DELISTED
Zynex
ZYXI
-2,022
Closed -$4.45K
FBLG icon
3561
FibroBiologics
FBLG
$4.81M
-141
Closed -$2.54K
ANRO icon
3562
Alto Neuroscience
ANRO
$1.06B
-2,135
Closed -$4.61K
GUTS icon
3563
Fractyl Health
GUTS
$107M
-3,192
Closed -$3.8K
KYTX icon
3564
Kyverna Therapeutics
KYTX
$457M
-2,769
Closed -$5.34K
MGX icon
3565
Metagenomi Therapeutics
MGX
$45.6M
-2,701
Closed -$3.69K
TELO icon
3566
Telomir Pharmaceuticals
TELO
$85.3M
-1,938
Closed -$6.27K
SMXT icon
3567
Solarmax Technology
SMXT
$20.3M
-2,224
Closed -$2.67K
QTTB icon
3568
Q32 Bio
QTTB
$451M
-523
Closed -$863
GCTS
3569
GCT Semiconductor Holding
GCTS
$184M
-1,197
Closed -$1.96K
BOLD
3570
Boundless Bio
BOLD
$57.8M
-1,449
Closed -$2.22K
CTNM
3571
Contineum Therapeutics
CTNM
$599M
-3,631
Closed -$25.3K
SKYE icon
3572
Skye Bioscience
SKYE
$20.5M
-1,486
Closed -$2.36K
VRN
3573
DELISTED
Veren
VRN
-864,979
Closed -$5.72M
ARTV
3574
Artiva Biotherapeutics
ARTV
$523M
-2,018
Closed -$6.05K
CLYM
3575
Climb Bio
CLYM
$676M
-2,581
Closed -$3.16K

Similar funds

Legal & General Group's Q2 2025 Portfolio in Review

As of Q2 2025, Legal & General Group held 3,602 positions worth $403B, up 9.7% from $367B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Legal & General Group's Q2 2025 filing shows 227 new, 1,896 increased, 1,081 reduced and 186 closed positions. Its largest new stake was Amrize Ltd: 3,253,080 shares worth $162M. The largest sale was Apple, an estimated $1.01B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Legal & General Group's largest Q2 2025 buy was Amrize Ltd: 3,253,080 shares worth $162M.
  • Legal & General Group added most to Tesla in Q2 2025, an estimated $342M increase.
  • Legal & General Group's biggest Q2 2025 reduction was Apple, cutting an estimated $1.01B.
  • Legal & General Group fully exited Discover Financial Services in Q2 2025, selling an estimated $296M.
  • Legal & General Group's ten largest holdings make up 32% of its $403B portfolio in Q2 2025.
  • Legal & General Group opened 227 new positions and closed 186 in Q2 2025.
  • Legal & General Group's portfolio value rose 9.7% quarter-over-quarter to $403B.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.